Jyong Biotech EBITDA Margin 1971-1970 | MENS
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Jyong Biotech (MENS) over the last 10 years. The current EBITDA margin for Jyong Biotech as of January 01, 1970 is .
| Jyong Biotech EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED-BIOMED/GENE | $0.722B | $0.000B |
| Jyong Biotech Ltd. is a science-driven biotechnology company. It involved in developing and commercializing new drugs mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. Jyong Biotech Ltd. is based in New Taipei City, Taiwan. | |||